Ultrasound Assessment of Breast Cancer After Chemotherapy
Author Information
Author(s): MT Seymour, EC Moskovic, G Walsh, P Trott, IE Smith
Primary Institution: The Royal Marsden Hospital
Hypothesis
The study aims to assess the usefulness of ultrasonography in evaluating breast abnormalities after primary chemotherapy for large operable breast cancer.
Conclusion
Ultrasound is a sensitive technique for assessing the response to primary medical therapy in breast cancer, particularly in patients who achieve complete clinical response.
Supporting Evidence
- 60% of patients achieved complete clinical response after chemotherapy.
- Ultrasound findings were not always indicative of residual cancer.
- Patients with Doppler positivity were more likely to have residual invasive carcinoma.
Takeaway
Doctors used ultrasound to check how well chemotherapy worked for breast cancer, and it helped them decide if surgery was needed.
Methodology
Patients were assessed using manual palpation and color Doppler ultrasound before and after chemotherapy, with histological evaluations performed on surgical specimens.
Potential Biases
The lack of blinding in assessments could lead to biased interpretations of ultrasound results.
Limitations
The study did not formally blind clinical and ultrasound assessments, which may introduce bias.
Participant Demographics
Patients were under 65 years old, with a median age of 45, and included both premenopausal and peri/post-menopausal women.
Want to read the original?
Access the complete publication on the publisher's website